Pharmaceutical company Avenacy has launched Propofol injectable emulsion, USP, in the U.S. to be used for intravenous general anesthetic and sedation. The drug has been approved by the FDA as a generic equivalent to general anesthetic Diprivan, according to an April 7 press release. It is approved for use for induction of general anesthesia in […]
The post FDA approves new general anesthetic appeared first on Becker’s ASC.